Immunocytochemical evidence that amyloid β (1-42) impairs endogenous antioxidant systems in vivo

Neuroscience

Volumn 119, Issue 2, 2003, Pages 399-419

  Kim, H C ^a   Yamada, K ^b   Nitta, A ^b   Olariu, A ^b   Tran, M H ^b   Mizuno, M ^b   Nakajima, A ^b   Nagai, T ^b   Kamei, H ^b   Jhoo, W K ^a   Im, D H ^a   Shin, E J ^a   Hjelle, O P ^c   Ottersen, O P ^c   Park, S C ^d   Kato, K ^e   Mirault, M E ^f   Nabeshima, T ^b  

^a Kangwon National University   (South Korea)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF OSLO   (Norway)

^d Seoul National University   (South Korea)

^e INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^f UNIVERSITÉ LAVAL   (Canada)

Author keywords

Alzheimer's disease; Glutathione; Glutathione peroxidase; Glutathione S transferase; Hippocampus; Superoxide dismutase

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL ENZYME;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN INDUCTION; PYRIFORM CORTEX; SUBSTANTIA NIGRA; THALAMUS;

EID: 0038400956     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00993-4     Document Type: Article

References (75)

1. Aksenov M.Y., Tucker H.M., Nair P., Aksenova M.V., Butterfield D.A., Estus S., Markesbery W.R. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J Mol Neurosci. 11:1998;151-164.
2. Behl C. Alzheimer's disease and oxidative stress implications for novel therapeutic approaches . Prog Neurobiol. 57:1999;301-323.
3. Behl C., Davis J., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem Biophys Res Commun. 186:1992;944-952.
4. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
5. Bruce-Keller A.J., Li Y.-J., Lovel M.A., Kraemer P.J., Gray D.S., Brown R.R., Markesbery W.R., Mattson M.P. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol. 57:1998;257-269.
6. Butterfield D.A., Hensley K., Harris M., Mattson M., Carney J. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion implications to Alzheimer's disease . Biochem Biophys Res Commun. 200:1994;710-715.
7. b subunits in oligodendrocytes and astrocytes of rat brain. J Neurochem. 52:1989;876-883.
8. Chasseaud L.F. The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res. 29:1979;175-274.
9. Dunford H.B. Free radicals in iron-containing systems. Free Rad Biol Med. 3:1987;405-421.
10. Floyd R.A., Carney J.M. Free radical damage to protein and DNA mechanism involved and relevant observations on brain undergoing oxidative stress . Ann Neurol. 32:1992;S22-S27.
11. Frey W.H.I.I., Najarian M.M., Kurma K.S., Emory C.R., Menning P.M., Frank J.C., Johnson N.M., Alta T.A. Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to muscarinic receptor. Brain Res. 724:1996;87-94.
12. Griffith O.W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem. 254:1979;7558-7560.
13. Gutzmann H., Hadler D., Erzigkeit H. Long-term treatment of Alzheimer's disease with idebenone. Iqbal K., Winblad B., Nishimura T., Takeda M., Wisniewski H.M. Alzheimer's disease: biology, diagnosis and therapeutics. 1997;687-705 Wiley & Sons, Chichester.
14. Hjelle O.P., Chaudhry F.A., Ottersen O.P. Antisera to glutathione characterization and immunocytochemical application to the rat cerebellum . Eur J Neurosci. 6:1994;793-804.
15. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
16. Itoh A., Nitta A., Nadai M., Nishimura K., Hirose M., Hasegawa T., Nabeshima T. Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J Neurochem. 66:1996;1113-1117.
17. Itoh A., Akaike T., Sokabe M., Nitta A., Iida R., Olariu A., Yamada K., Nabeshima T. Impairment of long-term potentiation in hippocampal slices of β-amyloid-infused rats. Eur J Pharmacol. 382:1999;167-175.
18. Janáky R., Ogita K., Pasqualotto B.A., Bains J.S., Oja S.S., Yoneda Y., Shaw C.A. Glutathione and signal transduction in the mammalian CNS. J Neurochem. 73:1999;889-902.
19. Jhoo W.-K., Kim H.-C., Yamada K., Im D.-H., Shin E.-J., Park S.J., Bing G.Y., Jang K.-J., Nabeshima T. Prolonged exposure to β-amyloid protein enhances 4-hydroxy-2-nonenal modified proteins in the rat brain. Soc Neurosci Abstr. 26:2000;1020.
20. Kim H.-C., Bing G., Jhoo W.-K., Ko K.H., Kim W.-K., Suh J.-H., Kim S.-J., Kato K., Hong J.-S. Changes of hippocampal Cu/Zn-superoxide dismutase after kainate treatment in the rat. Brain Res. 853:2000;215-226.
21. Kim H.-C., Jhoo W.-K., Kim W.-K., Suh J.-H., Shin E.J., Kato K., Ko K.H. An immunocytochemical study of mitochondrial manganese-superoxide dismutase in the rat hippocampus after kainate administration. Neurosci Lett. 281:2000;65-68.
22. Kim H.-C., Jhoo W.-K., Bing G., Shin E.J., Wie M.B., Kim W.-K., Ko K.H. Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Res. 874:2000;15-23.
23. Klein W.L., Krafft G.A., Finch C.E. Targeting small Aβ oligomers the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24:2001;219-224.
24. Koh J.-Y., Yang L.L., Cotman C.W. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
25. Kontuch A., Berndt C., Weber Akopyan V., Arlt S., Schippling S., Beisiegel U. Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic Biol Med. 30:2001;119-128.
26. Kurobe N., Kato K. Sensitive enzyme immunoassay for Rat Mn superoxide dismutase tissue distribution and developmental profiles in the rat central nervous tissue, liver and kidney . Biomed Res. 12:1991;97-103.
27. Liu X.-H., Kato H., Nakada N., Kogure K., Kato K. An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase in rat hippocampus after transient cerebral ischemia. Brain Res. 625:1993;29-37.
28. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
29. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging. 18:1997;457-461.
30. Lovell M.A., Xie C., Markesbery W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology. 51:1998;1562-1566.
31. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., Freedman M.L. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol. 150:1998;40-44.
32. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons involvement of membrane lipid peroxidation . J Neurosci. 17:1997;1046-1054.
33. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 23:1997;134-147.
34. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging. 19:1998;33-36.
35. Mattson M.P., Goodman Y. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676:1995;219-224.
36. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci. 12:1992;376-389.
37. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol. 36:1994;747-750.
38. Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 263:1988;17205-17208.
39. Michikawa M., Gong J.-S., Fan Q.-W., Sawamura N., Yanagisawa K. A novel action of Alzheimer's amyloid β-protein (Aβ) oligomeric Aβ promotes lipid release . J Neurosci. 21:2001;7226-7235.
40. Mirault M.-E., Tremblay A., Beaudoin N., Trembly M. Overexpression of seleno-glutathione peroxidase by gene transfer enhances the resistance of T47D human breast cells to clastogenic oxidants. J Biol Chem. 266:1991;20752-20760.
41. Mirault M.-E., Tremblay A., Furling D., Trépanier G., Dugré F., Puymirat J., Pothier F. Transgenic mice models for neuroprotection studies. Ann NY Acad Sci. 738:1994;104-115.
42. Miyamoto M., Coyle J.T. Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins. Exp Neurol. 108:1990;38-45.
43. Nitta A., Itoh A., Hasegawa T., Nabeshima T. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett. 170:1994;63-66.
44. Nitta A., Fukuta T., Hasegawa T., Nabeshima T. Continuous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol. 73:1997;51-57.
45. Olariu A., Tran M.H., Yamada K., Mizuno M., Hefco V., Nabeshima T. Memory deficits and increased emotionality induced by β-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus. J Neural Transm. 108:2001;1065-1079.
46. Ong W.Y., Hu C.Y., Hjelle O.P., Ottersen O.P., Halliwell B. Changes in glutathione in the hippocampus of rats injected with kainate depletion in neurons and upregulation in glia . Exp Brain Res. 132:2000;510-516.
47. Otieno M.A., Baggs R.B., Hayes J.D., Anders M.W. Immunolocalization of microsomal glutathione-S-transferase in rat tissues. Drug Metab Dispos. 25:1997;12-20.
48. Ottersen O.P. Postembedding light- and electromicroscopic immunocytochemistry of amino acids description of a new model system allowing identical conditions for specificity testing and tissue processing . Exp Brain Res. 69:1987;167-174.
49. Ottersen O.P., Storm-Mathisen J. Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique. J Comp Neurol. 229:1984;374-392.
50. Pappolla M.A., Chyan Y.-J., Hsiao K., Perry G., Smith M.A., Bozner P. Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease a chronic oxidative paradigm for testing antioxidant therapies in vivo . Am J Pathol. 152:1998;871-877.
51. Park S.C., Kwak S.J., Kim E.G., Rha Y.H., Song K.Y., Kim S.T. Immunohistochemical location and biosignificance of glutathione transferase isozymes in human hepatoma tissue. Kor J Biochem. 22:1990;147-155.
52. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
53. Ratan R.R., Murphy T.H., Baraban J.M. Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis by shunting cystein to glutathione. J Neurosci. 14:1994;4385-4392.
54. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med. 336:1997;1216-1222.
55. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA. 92:1995;1989-1993.
56. Selkoe D.J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8:1998;447-453.
57. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;23-31.
58. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease. Proc Natl Acad Sci USA. 88:1991;10540-10543.
59. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L.R., Siedlak S.L., Tabaton M., Perry G. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem. 70:1998;2212-2215.
60. Song K.Y., Lim I.K., Park S.C., Lee S.O., Park H.S., Choi Y.K., Hyun B.H. Effect of nodularin on the expression of glutathione-S-transferase placental form and proliferating cell nuclear antigen in N-nitrosodiethylamine initiated hepaticarcinogenesis in the male Fisher 344 rat. Carcinogenesis. 20:1999;1541-1548.
61. Sonnenberg J.L., MacGregon-Leon P.F., Curran T., Morgan J.L. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron. 3:1989;359-365.
62. Subbarao K.V., Richardson J.S., Ang L.C. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem. 55:1990;342-345.
63. Suno M., Nagaoka A. Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition. Biochem Biophys Res Commun. 125:1984;1046-1052.
64. Tang Y.-P., Yamada K., Kanou Y., Miyazaki T., Xiong X.-L., Kambe F., Murata Y., Seo H., Nabeshima T. Spatiotemporal expression of BDNF in the hippocampus induced by the continuous intracerebroventricular infusion of β-amyloid in rats. Mol Brain Res. 80:2000;188-197.
65. Trépanier G., Furling D., Puymirat J., Mirault M.-E. Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain. Neuroscience. 75:1996;231-243.
66. Tran M.H., Yamada K., Olariu A., Mizuno M., Ren X.H., Nabeshima T. Amyloid β-peptide induces nitric oxide production in rat hippocampus association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors . FASEB J. 15:2001;1407-1409.
67. Tran M.H., Yamada K., Nakajima A., Mizuno M., He J., Kamei H., Nabeshima T. Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid β-peptide-induced cholinergic dysfunction. Mol Psychiatry. 2002;. in press.
68. Yamada K., Nabeshima T. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther. 88:2000;93-113.
69. Yamada K., Nitta A., Saito T., Hu J., Nabeshima T. Changes in ciliary neurotrophic factor content in the rat brain after continuous intracerebroventricular infusion of β-amyloid (1-40) protein. Neurosci Lett. 201:1995;155-158.
70. Yamada K., Ren X., Nabeshima T. Perspectives of pharmacotherapy in Alzheimer's disease. Jpn J Pharmacol. 80:1999;9-14.
71. Yamada K., Tanaka T., Han D., Senzaki K., Kameyama T., Nabeshima T. Protective effects of idebenone and α-tocopherol on β-amyloid-(1-42) induced learning and memory deficits in rats implication of oxidative stress in β-amyloid-induced neurotoxicity in vivo . Eur J Neurosci. 11:1999;83-90.
72. Yamada K., Tanaka T., Zou L.-B., Senzaki K., Yano K., Osada T., Olariu A., Ren X., Kameyama T., Nabeshima T. Long-term deprivation of oestrogens by ovariectomy potentiates β-amyloid-induced working memory deficits in rats. Br J Pharmacol. 128:1999;419-427.
73. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein reversal by tachykinin neuropeptides . Science. 250:1990;279-282.
74. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
75. Zou K., Gong J.-S., Yanagisawa K., Michikawa M. A novel function of monomeric amyloid β-protein serving as an antioxidant molecule against metal-induced oxidative damage. J Neurosci. 22:2002;4833-4841.